Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,557,460
+$2,506,462 QoQ
Shares Held
77,720
-0.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#617
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $83,001,641 across 13 Drug Manufacturers - General names. ABBV ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,391 | $26,856,439 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
77,720 | $19,557,460 | |
| 3 | JNJ |
Johnson & Johnson
|
68,669 | $17,439,865 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,166 | $6,060,831 | |
| 5 | AMGN |
Amgen Inc
|
12,332 | $4,465,663 | |
| 6 | NVS |
Novartis AG
|
21,792 | $3,415,242 | |
| 7 | PFE |
Pfizer Inc
|
71,411 | $1,719,576 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,687 | $788,644 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,557,460 | 77,720 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $17,050,998 | 78,399 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,293,621 | 71,310 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,312,708 | 74,772 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,586,205 | 78,581 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,207,249 | 82,127 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $14,949,901 | 84,130 | Shares | Sole | 2025-02-24 | |
| 2024-09-30 | $16,366,352 | 82,876 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,929,996 | 81,215 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $13,101,184 | 71,945 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,846,483 | 63,538 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,182,394 | 61,602 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $7,604,565 | 56,443 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,003,242 | 50,218 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,764,671 | 41,858 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $5,689,832 | 42,395 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $6,857,585 | 44,774 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $6,298,297 | 38,852 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,093,883 | 37,621 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,077,701 | 37,802 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,161,259 | 36,943 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $3,422,241 | 31,623 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $2,405,838 | 22,453 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,990,044 | 22,720 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $2,051,962 | 20,900 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,317,934 | 17,298 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||